2 Matching Annotations
  1. Feb 2022
  2. Nov 2021
    1. Some 775 people with Covid took part in the study. Among the half of patients taking molnupiravir twice a day, 7.3 per cent were admitted to hospital over the course of 30 days. This compares with 14.1 per cent of the second group of patients who were given a placebo pill.